Risk of mortality among inpatients with COVID-19 and type 2 diabetes: National data from Kuwait.
Endocrinol Diabetes Metab
; 4(4): e00287, 2021 10.
Article
in English
| MEDLINE | ID: covidwho-1306644
ABSTRACT
INTRODUCTION:
To investigate type 2 diabetes as a risk factor for COVID-19 death following hospital admission in Kuwait.METHODS:
A retrospective cohort study using data from a central hospital that cared for all hospitalized COVID-19 patients in Kuwait. We investigated the association between type 2 diabetes, with COVID-19 mortality using multiply imputed logistic regression and calculated the population attributable fraction.RESULTS:
A total of 5333 patients were admitted with COVID-19, of whom 244 died (4.6%). Diabetes prevalence was 24.8%, but 53.7% of those who died had diabetes. After adjusting for age, sex, ethnicity and other comorbidities, diabetes was associated with death (OR 1.70 [95% CI 1.23, 2.34]) and admission to the intensive care unit more than 3 days after initial admission (OR 1.78 [95% CI 1.17, 2.70]). Assuming causality, the population attributable fraction for type 2 diabetes in COVID-19 death was 19.6% (95% CI 10.8, 35.6).CONCLUSION:
Type 2 diabetes is a strong risk factor for COVID-19 death in the Middle East. Given the high prevalence of type 2 diabetes in the Middle East, as well as many Western countries, the public health implications are considerable.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Diabetes Mellitus, Type 2
/
COVID-19
Type of study:
Cohort study
/
Observational study
/
Prognostic study
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
Endocrinol Diabetes Metab
Year:
2021
Document Type:
Article
Affiliation country:
Edm2.287
Similar
MEDLINE
...
LILACS
LIS